Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 134 | 7 | 4 | 45 | 231 |
| Receivables | 31 | 23 | 1 | 2 | 18 |
| TOTAL | $202 | $186 | $5 | $47 | $248 |
| Non-Current Assets | |||||
| PPE Net | 5 | 2 | N/A | N/A | N/A |
| Intangibles | 1,131 | 1,402 | N/A | 0 | 0 |
| TOTAL | $1,136 | $1,404 | $0 | $0 | $0 |
| Total Assets | $1,338 | $1,590 | $5 | $47 | $248 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 58 | 58 | 30 | 45 | N/A |
| TOTAL | $63 | $70 | $49 | $45 | $46 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $63 | $70 | $49 | $45 | $46 |
| Shareholders' Equity | |||||
| Common Shares | 25,510 | 27,558 | 25,866 | 0 | 0 |
| Retained earnings | -28,956 | -29,666 | -28,913 | -29,861 | -31,160 |
| TOTAL | $1,276 | $1,520 | $-44 | $3 | $202 |
| Total Liabilities And Equity | $1,338 | $1,590 | $5 | $47 | $248 |